Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvsef crawled time : 13:00 save search
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
Published: 2024-01-11 (Crawled : 13:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.22%
H: 0.43%
C: 0.37%
LNTH | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: 0.32%
H: 0.03%
C: -4.42%
lutathera
Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
ERAS | $1.79 0.0% 570K
|
|
| O: 1.07%
H: 0.0%
C: -2.65%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
fda melanoma granted designation advanced
Dyadic Appoints Doug Pace to Its Executive Leadership Team
Published: 2023-10-09 (Crawled : 13:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.21%
H: 1.24%
C: 0.42%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.01%
H: 0.47%
C: 0.45%
DYAI A | $1.61 1.26% 1.24% 14K
|
Health Technology
|
| O: -2.45%
H: 0.0%
C: -2.01%
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
Published: 2023-10-03 (Crawled : 13:00) - biospace.com/
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 2.22%
H: 0.87%
C: -0.65%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.6%
H: 0.36%
C: -0.46%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.1%
H: 0.74%
C: -1.67%
xolair biosimilar commercialization agreement
Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.13%
H: 0.06%
C: -1.02%
CERS | $1.675 2.13% 2.09% 980K
|
Health Technology
|
| O: -1.3%
H: 5.92%
C: 0.66%
corporation
Sandoz signs Memorandum of Understanding to build new biologics production plant in Slovenia, to support increasing global demand for biosimilar medicines
Published: 2023-03-09 (Crawled : 13:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -5.6%
H: 1.19%
C: 1.19%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -3.04%
H: 0.16%
C: -0.9%
global biosimilar
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Global Precision Medicine Market Competitive Landscape and Trends - By The Business Research Company
Published: 2023-01-31 (Crawled : 13:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: -1.15%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.37%
H: 1.5%
C: 1.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.09%
H: 1.19%
C: 1.18%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.21%
H: 1.16%
C: 1.14%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
research global trends market
Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.56%
H: 0.73%
C: 0.17%
market ophthalmic emulsion
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published: 2023-01-13 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.13%
H: 0.76%
C: 0.76%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.77%
H: 0.63%
C: 0.63%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.13%
H: 2.35%
C: 2.16%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.44%
H: 1.39%
C: 0.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.15%
H: 0.65%
C: 0.4%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.47%
H: 0.47%
C: 0.14%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.13%
H: 1.04%
C: 0.57%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -1.16%
H: 2.27%
C: 0.42%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.27%
H: 0.78%
C: 0.15%
treatment disease expected
Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -1.13%
H: 28.57%
C: 19.0%
CSLLY | $86.918 3.3% 60K
|
n/a
|
| O: -3.93%
H: 2.17%
C: 1.75%
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: 3.1%
H: 0.0%
C: -2.75%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.2%
H: 2.06%
C: 2.06%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.09%
H: 0.54%
C: 0.54%
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
|
| O: 1.0%
H: 0.0%
C: -0.26%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 3.43%
H: 0.0%
C: -2.93%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.54%
H: 2.5%
C: 1.7%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.43%
H: 0.84%
C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.42%
H: 1.35%
C: 1.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.28%
H: 1.26%
C: 1.15%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.57%
H: 1.35%
C: 1.0%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.48%
H: 3.96%
C: -0.48%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.27%
H: 0.6%
C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.67%
H: 0.66%
C: 0.3%
pharma global market
Cell Therapy Market Value to Reach US$ 54.6 Bn by 2032, States TMR Study
Published: 2022-12-19 (Crawled : 13:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.0%
H: 0.09%
C: -0.32%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: -0.49%
H: 0.02%
C: -6.55%
therapy study market
Outlook on the Age-related Macular Degeneration Global Market to 2030 - Players Include Bayer, Pfizer, Bausch Health and Amgen Among Others
Published: 2022-12-14 (Crawled : 13:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.74%
H: 0.45%
C: -1.8%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.0%
H: 1.29%
C: 0.45%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.39%
H: 3.26%
C: 2.34%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.11%
H: 0.51%
C: -0.31%
global macular health market
Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib
Published: 2022-12-09 (Crawled : 13:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.55%
H: 0.39%
C: 0.39%
ERAS | $1.79 0.0% 570K
|
|
| O: -9.03%
H: 0.75%
C: -14.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.24%
H: 0.32%
C: -0.93%
license
The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR
Published: 2022-11-22 (Crawled : 13:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.53%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.77%
H: 0.41%
C: 0.27%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.66%
H: 0.79%
C: 0.72%
ALIM | $3.41 -0.87% -0.88% 48K
|
Health Technology
|
| O: 0.47%
H: 7.5%
C: -1.17%
expected diabetic
Seagen Names David R. Epstein as Chief Executive Officer and Director
Published: 2022-11-10 (Crawled : 13:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -1.69%
H: 0.1%
C: -3.37%
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-08 (Crawled : 13:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.54%
H: 1.08%
C: 0.57%
SWTX | $40.075 -5.64% -5.98% 1.4M
|
Health Technology
|
| O: 1.64%
H: 4.18%
C: -1.53%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: -0.81%
H: 6.5%
C: 3.25%
financial update results
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT2606, a Proposed Biosimilar of Nucala® (mepolizumab) Bio-Thera Solutions, Ltd. announced that dosing has begun in a Phase I cli...
Published: 2022-10-14 (Crawled : 13:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.8%
C: -0.75%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -2.63%
H: 2.37%
C: -2.5%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
DVA | $127.82 1.36% 0.0% 490K
|
Health Services
|
| O: 0.65%
H: 1.88%
C: -0.77%
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.4%
H: 1.39%
C: -0.3%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.24%
H: 1.71%
C: 1.01%
NNVC | $1.1 -6.38% 0.0% 22K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
bat2606 nucala solutions biosimilar study
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: -0.21%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.2%
H: 0.44%
C: 0.24%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 1.32%
H: 1.12%
C: 0.34%
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: 0.43%
H: 3.12%
C: 0.85%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 1.7%
H: 4.68%
C: 3.43%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.06%
H: 0.81%
C: -0.01%
Human Papillomavirus Vaccine (HPV) Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR: Allied Market Research
Published: 2022-07-21 (Crawled : 13:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 6.64%
H: 0.0%
C: -4.08%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.38%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: -3.5%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.09%
H: 1.9%
C: 1.89%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.3%
H: 0.38%
C: -0.38%
XBIO | $4.14 7.32% 770
|
Health Technology
|
| O: 0.41%
H: 7.44%
C: -2.71%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.38%
H: 0.0%
C: 0.0%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 0.0%
H: 1.35%
C: -5.83%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.75%
H: 2.31%
C: 2.15%
research vaccine market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.